Morning, ladies and gentlemen. We welcome everyone here today to the 2026 Rockwell Medical Annual Meeting of Stockholders, which is being held as a virtual meeting. I am Mark Strobeck, President and CEO of Rockwell Medical, and I will act as chairman of this meeting. I now call the meeting to order. As a preliminary matter, a virtual meeting is one that takes place via an electronic format. An audio feed from this meeting is being webcast as we speak. This webcast incorporates stockholder validation capabilities, which allows stockholders to vote in real time during the meeting until the polls are closed. We believe that holding a virtual meeting expands stockholder access. Our stockholders can virtually attend this meeting, and other interested parties can listen to this webcast online.
If you are a stockholder and entered this meeting by using your 16-digit control number found on your proxy card, you will be able to vote your shares. If you are a stockholder and did not enter this meeting by using your 16-digit control number found on your proxy card, you will not be able to vote your shares unless you enter the control number. It is approximately 10:00 A.M. Eastern Time. The polls are now open. Please note that the polls will close in a few minutes, so we urge you to vote your shares now if you have not already submitted a proxy or otherwise voted. If you have already submitted your proxy, you do not need to vote again. You may revoke your proxy by voting online at this meeting. Thank you very much to those who are participating in our meeting today.
I am joined by the following members of the Rockwell leadership team: Megan Timmins, our Executive Vice President, Chief Legal Officer, and Secretary; Jesse Neri, our Senior Vice President and Chief Financial Officer; Tim Chole, our Senior Vice President and Chief Commercial Officer; Heather Hunter, our Senior Vice President and Chief Operating Officer; and Leslie Spriggs, our Vice President of Human Resources. Lee Tomasso, a representative from Rockwell's independent registered public accounting firm, EisnerAmper, is also present and will be available to respond to appropriate questions later in the meeting. Megan Timmins will act as secretary of this meeting. John Holewa from American Election Services will act as the inspector of elections. Mr. Holewa has taken the customary oath of office, which will be filed with the permanent records of this meeting. At this time, we will commence the formal business of today's meeting.
Now, will the secretary please report on the notice and call of the meeting?
Mr. Chairman, the notice of meeting was mailed beginning on or around April 30, 2026, to all stockholders as of the April 16, 2026, record date of the meeting. Copies of the proxy materials that were mailed on or around April 30, 2026, were available to stockholders and were posted on the virtual meeting site. I will file the list of stockholders with the records of the company and file the notice of meeting and proxy statement, proxy card, annual report, and affidavit of mailing with the minutes of the meeting.
Thank you. The notice of meeting and the affidavit as to its mailing shall be made a part of the minutes of this meeting. Will the secretary please report on stockholder attendance at the meeting?
Mr. Chairman, there were 39,405,302 shares of common stock issued and outstanding as of the record date for this meeting, each having one vote. The inspector of election appointed for the meeting has provided a preliminary tabulation of written proxies received, which indicates that there are stockholders present by proxy representing approximately 23,813,706 shares of common stock, or approximately 60% of the total number of shares eligible to vote at the meeting.
Legal notice of the meeting has been given and a quorum is present, and therefore this annual meeting is properly legally convened and ready to transact the legal portion of this meeting. This meeting has been called to consider and vote upon the following items of business, each of which is described in detail in the company's 2026 proxy statement, dated April 30, 2026. Election of two Class II directors, Joseph Dawson and Joan Lau, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified. Approval on an advisory basis of the compensation of our named executive officers. Ratification of the selection of EisnerAmper as our independent registered public accounting firm for 2026.
Approval and adoption of an amendment to the company's certificate of incorporation to effect a reverse stock split of the company's common stock. It is now 10:05 A.M., and the polls are officially closed. The first item of business for stockholder consideration is the election of Joseph Dawson and Joan Lau, each to a three-year term as a Class II director. Madam Secretary, will you please report on the number of votes cast for the election of Directors Dawson and Lau?
Mr. Chairman, a preliminary tabulation provided by the Inspector of Elections indicates that Director Dawson received approximately 89% of the votes cast, and Director Lau received approximately 90% of the votes cast.
As indicated by the vote, each director nominee has been reelected. The second item of business to be presented for stockholder consideration at this meeting is a resolution approving on an advisory basis the compensation of our named executive officers as disclosed in the Compensation of Executive Officers section and the accompanying compensation tables and narrative discussion contained in the proxy statement. Will the secretary please report on the number of shares cast for the approval of the compensation of our named executive officers?
Mr. Chairman, a preliminary tabulation provided by the Inspector of Elections indicates that the compensation of our named executive officers has been approved by approximately 75% of the votes cast.
As indicated by the vote, I hereby declare that stockholders have approved the compensation of our named executive officers on an advisory basis. The third item of business for stockholder consideration at this meeting is the ratification of the appointment of EisnerAmper to serve as the company's independent registered public accounting firm for 2026. Will the secretary please report on the number of shares cast for the ratification of the appointment of EisnerAmper?
Mr. Chairman, a preliminary tabulation provided by the Inspector of Election indicates that the ratification of the appointment of EisnerAmper to serve as the company's independent registered public accounting firm for 2026 has been approved by approximately 97% of the votes cast.
I hereby declare the appointment of EisnerAmper to serve as the company's independent registered accounting firm for 2026 as approved. The fourth item of business for stockholder consideration at this meeting is the approval and adoption of an amendment to the company's certificate of incorporation to effect a reverse stock split. Will the secretary please report on the number of votes cast for the approval of the amendment to the company's certificate of incorporation to effect a reverse stock split?
Mr. Chairman, a preliminary tabulation provided by the Inspector of Election indicates that the adoption of an amendment to the company's certificate of incorporation to effect a reverse stock split has been approved by approximately 71% of the votes cast.
As indicated by the vote, I hereby declare that stockholders have approved the adoption of an amendment to the company's certificate of incorporation to effect a reverse stock split. At this time, the meeting is hereby adjourned. Final voting results will be published in a current report on Form 8-K to be filed with the SEC within four business days after the annual meeting. I would like to address questions you may have with the allotted time. We've allotted up to 10 minutes to answer questions germane to the meeting. Before I answer questions, I wanted to note that certain matters we have and will discuss may be forward-looking statements intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified as such because the context of the statement will include words such as "we believe," "anticipate," "expect" or words of similar import. Similar statements that describe our future plans, objectives, strategies, or goals are also forward-looking statements. These forward-looking statements are subject to certain risks and uncertaintes that they materially adversely affect our anticipated results. Risks and uncertainties include, but are not limited to, the factors described in our annual report on Form 10-K for the year end December 31st, 2025. Copies of our SEC filings are available on the SEC's website, which is www.sec.gov, and in the Investors section of our website located at rockwellmedical.com. We disclaim any obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Are there any questions at this time? As there are no questions, I would like to conclude by thanking everyone for participating in this year's annual meeting of the stockholders of Rockwell Medical. Goodbye.
This concludes today's meeting. You may now disconnect.